Control of heparin therapy with an activated partial thromboplastin time. 1973

J W Akkerman, and J J Sixma, and B N Bouma

UI MeSH Term Description Entries
D007201 Indicator Dilution Techniques Methods for assessing flow through a system by injection of a known quantity of an indicator, such as a dye, radionuclide, or chilled liquid, into the system and monitoring its concentration over time at a specific point in the system. (From Dorland, 28th ed) Dilution Techniques,Dilution Technics,Indicator Dilution Technics,Dilution Technic,Dilution Technic, Indicator,Dilution Technics, Indicator,Dilution Technique,Dilution Technique, Indicator,Dilution Techniques, Indicator,Indicator Dilution Technic,Indicator Dilution Technique,Technic, Dilution,Technic, Indicator Dilution,Technics, Dilution,Technics, Indicator Dilution,Technique, Dilution,Technique, Indicator Dilution,Techniques, Dilution,Techniques, Indicator Dilution
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

J W Akkerman, and J J Sixma, and B N Bouma
June 1969, Current therapeutic research, clinical and experimental,
J W Akkerman, and J J Sixma, and B N Bouma
March 1971, Canadian Medical Association journal,
J W Akkerman, and J J Sixma, and B N Bouma
June 1967, Southern medical journal,
J W Akkerman, and J J Sixma, and B N Bouma
May 1980, World journal of surgery,
J W Akkerman, and J J Sixma, and B N Bouma
June 1998, Archives of internal medicine,
J W Akkerman, and J J Sixma, and B N Bouma
April 1979, American journal of clinical pathology,
J W Akkerman, and J J Sixma, and B N Bouma
June 1969, Missouri medicine,
J W Akkerman, and J J Sixma, and B N Bouma
November 1970, Australasian annals of medicine,
J W Akkerman, and J J Sixma, and B N Bouma
March 1971, American journal of clinical pathology,
J W Akkerman, and J J Sixma, and B N Bouma
April 1989, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!